APO Research
Talk to an analyst

APO RESEARCH · REPORT

Icodec Insulin

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Icodec Insulin Market Outlook and Growth Opportunities 2026

29 December 2025199 pages

Choose your research edition.

Industry ResearchIcodec Insulin Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Icodec Insulin Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Icodec Insulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Icodec Insulin Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Icodec Insulin Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Icodec Insulin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Icodec Insulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Icodec Insulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Icodec Insulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Icodec Insulin market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Icodec Insulin market include Paijin Biotechnology, Sanofi, Lilly, Gan&Lee Pharmaceuticals and Novo Nordisk, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Icodec Insulin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Icodec Insulin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Icodec Insulin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Icodec Insulin market size, projected growth trends, production technologies, key applications, and end-use industries.

Icodec Insulin Segment by Company

Paijin Biotechnology

Sanofi

Lilly

Gan&Lee Pharmaceuticals

Novo Nordisk

Icodec Insulin Segment by Type

Long-acting

Medium-acting

Icodec Insulin Segment by Application

Hospital

Clinic

Icodec Insulin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Icodec Insulin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Icodec Insulin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Icodec Insulin significant trends, drivers, influence factors in global and regions.

6. To analyze Icodec Insulin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Icodec Insulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Icodec Insulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Icodec Insulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Icodec Insulin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Icodec Insulin industry.

Chapter 3: Detailed analysis of Icodec Insulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Icodec Insulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Icodec Insulin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Icodec Insulin Industry Trends Table 2. Icodec Insulin Industry Drivers Table 3. Icodec Insulin Industry Opportunities and Challenges Table 4. Icodec Insulin Industry Restraints Table 5. Global Icodec Insulin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Icodec Insulin Revenue Share by Company (2021-2026) Table 7. Global Icodec Insulin Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Icodec Insulin Sales Volume Share by Company (2021-2026) Table 9. Global Icodec Insulin Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Icodec Insulin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Icodec Insulin Key Company Manufacturing Base & Headquarters Table 12. Global Icodec Insulin Company, Product Type & Application Table 13. Global Icodec Insulin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Icodec Insulin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Long-acting Table 18. Significant Companies of Medium-acting Table 19. Global Icodec Insulin Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Icodec Insulin Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Icodec Insulin Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Icodec Insulin Sales Volume Share by Type (2021-2026) Table 23. Global Icodec Insulin Sales Volume Share by Type (2027-2032) Table 24. Global Icodec Insulin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Icodec Insulin Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Icodec Insulin Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Icodec Insulin Sales Value Share by Type (2021-2026) Table 28. Global Icodec Insulin Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Global Icodec Insulin Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Icodec Insulin Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Icodec Insulin Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Icodec Insulin Sales Volume Share by Application (2021-2026) Table 35. Global Icodec Insulin Sales Volume Share by Application (2027-2032) Table 36. Global Icodec Insulin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Icodec Insulin Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Icodec Insulin Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Icodec Insulin Sales Value Share by Application (2021-2026) Table 40. Global Icodec Insulin Sales Value Share by Application (2027-2032) Table 41. Global Icodec Insulin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Icodec Insulin Sales by Region (2021-2026) & (K Units) Table 43. Global Icodec Insulin Sales Market Share by Region (2021-2026) Table 44. Global Icodec Insulin Sales by Region (2027-2032) & (K Units) Table 45. Global Icodec Insulin Sales Market Share by Region (2027-2032) Table 46. Global Icodec Insulin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Icodec Insulin Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Icodec Insulin Sales Value Share by Region (2021-2026) Table 49. Global Icodec Insulin Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Icodec Insulin Sales Value Share by Region (2027-2032) Table 51. Global Icodec Insulin Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Icodec Insulin Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Icodec Insulin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Icodec Insulin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Icodec Insulin Sales by Country (2021-2026) & (K Units) Table 56. Global Icodec Insulin Sales Market Share by Country (2021-2026) Table 57. Global Icodec Insulin Sales by Country (2027-2032) & (K Units) Table 58. Global Icodec Insulin Sales Market Share by Country (2027-2032) Table 59. Global Icodec Insulin Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Icodec Insulin Sales Value Market Share by Country (2021-2026) Table 61. Global Icodec Insulin Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Icodec Insulin Sales Value Market Share by Country (2027-2032) Table 63. Paijin Biotechnology Company Information Table 64. Paijin Biotechnology Business Overview Table 65. Paijin Biotechnology Icodec Insulin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Paijin Biotechnology Icodec Insulin Product Portfolio Table 67. Paijin Biotechnology Recent Development Table 68. Sanofi Company Information Table 69. Sanofi Business Overview Table 70. Sanofi Icodec Insulin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Sanofi Icodec Insulin Product Portfolio Table 72. Sanofi Recent Development Table 73. Lilly Company Information Table 74. Lilly Business Overview Table 75. Lilly Icodec Insulin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Lilly Icodec Insulin Product Portfolio Table 77. Lilly Recent Development Table 78. Gan&Lee Pharmaceuticals Company Information Table 79. Gan&Lee Pharmaceuticals Business Overview Table 80. Gan&Lee Pharmaceuticals Icodec Insulin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Gan&Lee Pharmaceuticals Icodec Insulin Product Portfolio Table 82. Gan&Lee Pharmaceuticals Recent Development Table 83. Novo Nordisk Company Information Table 84. Novo Nordisk Business Overview Table 85. Novo Nordisk Icodec Insulin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Novo Nordisk Icodec Insulin Product Portfolio Table 87. Novo Nordisk Recent Development Table 88. Key Raw Materials Table 89. Raw Materials Key Suppliers Table 90. Icodec Insulin Distributors List Table 91. Icodec Insulin Customers List Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. Icodec Insulin Product Image Figure 2. Global Icodec Insulin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Icodec Insulin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Icodec Insulin Sales (2021-2032) & (K Units) Figure 5. Global Icodec Insulin Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Icodec Insulin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Long-acting Image Figure 10. Medium-acting Image Figure 11. Global Icodec Insulin Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Icodec Insulin Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Icodec Insulin Sales Volume Share by Type (2021-2032) Figure 14. Global Icodec Insulin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Icodec Insulin Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Icodec Insulin Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Global Icodec Insulin Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Icodec Insulin Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Icodec Insulin Sales Volume Share by Application (2021-2032) Figure 22. Global Icodec Insulin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Icodec Insulin Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Icodec Insulin Sales Value Share by Application (2021-2032) Figure 25. Global Icodec Insulin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Icodec Insulin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Icodec Insulin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Icodec Insulin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Icodec Insulin Sales Value (2021-2032) & (US$ Million) Figure 30. North America Icodec Insulin Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Icodec Insulin Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Icodec Insulin Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Icodec Insulin Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Icodec Insulin Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Icodec Insulin Sales Value (2021-2032) & (US$ Million) Figure 36. South America Icodec Insulin Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Icodec Insulin Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Icodec Insulin Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Icodec Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Icodec Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Icodec Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Icodec Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Icodec Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Icodec Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Icodec Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Icodec Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Icodec Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Icodec Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Icodec Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Icodec Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Icodec Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Icodec Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Icodec Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Icodec Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Icodec Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Icodec Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Icodec Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Icodec Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Icodec Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Icodec Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Icodec Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Icodec Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Icodec Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Icodec Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Icodec Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Icodec Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Icodec Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Icodec Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Icodec Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Icodec Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Icodec Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Icodec Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Icodec Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Icodec Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Icodec Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Icodec Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Icodec Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Icodec Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Icodec Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Icodec Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Icodec Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Icodec Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Icodec Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Icodec Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Icodec Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Icodec Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Icodec Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Icodec Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Icodec Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Icodec Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Icodec Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Icodec Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Icodec Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Icodec Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Icodec Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Icodec Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Icodec Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Icodec Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Icodec Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Icodec Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Icodec Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Icodec Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Icodec Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Icodec Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Icodec Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Icodec Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Icodec Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Icodec Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Icodec Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Icodec Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Icodec Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Icodec Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Icodec Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Icodec Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Icodec Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Icodec Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Icodec Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Icodec Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Icodec Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Icodec Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Icodec Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Icodec Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Icodec Insulin Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Icodec Insulin Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Long-acting
  • Medium-acting
Applications
  • Hospital
  • Clinic
Companies covered
  • Paijin Biotechnology
  • Sanofi
  • Lilly
  • Gan&Lee Pharmaceuticals
  • Novo Nordisk

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Icodec Insulin Sales Value (2021-2032)
  4. 1.2.2 Global Icodec Insulin Sales Volume (2021-2032)
  5. 1.2.3 Global Icodec Insulin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Icodec Insulin Market Dynamics
  1. 2.1 Icodec Insulin Industry Trends
  2. 2.2 Icodec Insulin Industry Drivers
  3. 2.3 Icodec Insulin Industry Opportunities and Challenges
  4. 2.4 Icodec Insulin Industry Restraints
3 Icodec Insulin Market by Company
  1. 3.1 Global Icodec Insulin Company Revenue Ranking in 2025
  2. 3.2 Global Icodec Insulin Revenue by Company (2021-2026)
  3. 3.3 Global Icodec Insulin Sales Volume by Company (2021-2026)
  4. 3.4 Global Icodec Insulin Average Price by Company (2021-2026)
  5. 3.5 Global Icodec Insulin Company Ranking (2024-2026)
  6. 3.6 Global Icodec Insulin Company Manufacturing Base and Headquarters
  7. 3.7 Global Icodec Insulin Company Product Type and Application
  8. 3.8 Global Icodec Insulin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Icodec Insulin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Icodec Insulin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Icodec Insulin Market by Type
  1. 4.1 Icodec Insulin Type Introduction
  2. 4.1.1 Long-acting
  3. 4.1.2 Medium-acting
  4. 4.2 Global Icodec Insulin Sales Volume by Type
  5. 4.2.1 Global Icodec Insulin Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Icodec Insulin Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Icodec Insulin Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Icodec Insulin Sales Value by Type
  9. 4.3.1 Global Icodec Insulin Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Icodec Insulin Sales Value by Type (2021-2032)
  11. 4.3.3 Global Icodec Insulin Sales Value Share by Type (2021-2032)
5 Icodec Insulin Market by Application
  1. 5.1 Icodec Insulin Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Icodec Insulin Sales Volume by Application
  5. 5.2.1 Global Icodec Insulin Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Icodec Insulin Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Icodec Insulin Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Icodec Insulin Sales Value by Application
  9. 5.3.1 Global Icodec Insulin Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Icodec Insulin Sales Value by Application (2021-2032)
  11. 5.3.3 Global Icodec Insulin Sales Value Share by Application (2021-2032)
6 Icodec Insulin Regional Sales and Value Analysis
  1. 6.1 Global Icodec Insulin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Icodec Insulin Sales by Region (2021-2032)
  3. 6.2.1 Global Icodec Insulin Sales by Region: 2021-2026
  4. 6.2.2 Global Icodec Insulin Sales by Region (2027-2032)
  5. 6.3 Global Icodec Insulin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Icodec Insulin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Icodec Insulin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Icodec Insulin Sales Value by Region (2027-2032)
  9. 6.5 Global Icodec Insulin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Icodec Insulin Sales Value (2021-2032)
  12. 6.6.2 North America Icodec Insulin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Icodec Insulin Sales Value (2021-2032)
  15. 6.7.2 Europe Icodec Insulin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Icodec Insulin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Icodec Insulin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Icodec Insulin Sales Value (2021-2032)
  21. 6.9.2 South America Icodec Insulin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Icodec Insulin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Icodec Insulin Sales Value Share by Country, 2025 VS 2032
7 Icodec Insulin Country-level Sales and Value Analysis
  1. 7.1 Global Icodec Insulin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Icodec Insulin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Icodec Insulin Sales by Country (2021-2032)
  4. 7.3.1 Global Icodec Insulin Sales by Country (2021-2026)
  5. 7.3.2 Global Icodec Insulin Sales by Country (2027-2032)
  6. 7.4 Global Icodec Insulin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Icodec Insulin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Icodec Insulin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Icodec Insulin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Icodec Insulin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Icodec Insulin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Icodec Insulin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Icodec Insulin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Icodec Insulin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Icodec Insulin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Icodec Insulin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Icodec Insulin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Icodec Insulin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Icodec Insulin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Icodec Insulin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Icodec Insulin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Icodec Insulin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Icodec Insulin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Icodec Insulin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Icodec Insulin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Icodec Insulin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Icodec Insulin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Icodec Insulin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Icodec Insulin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Icodec Insulin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Icodec Insulin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Icodec Insulin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Icodec Insulin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Icodec Insulin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Icodec Insulin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Icodec Insulin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Icodec Insulin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Icodec Insulin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Icodec Insulin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Icodec Insulin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Icodec Insulin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Icodec Insulin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Icodec Insulin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Icodec Insulin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Icodec Insulin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Icodec Insulin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Icodec Insulin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Icodec Insulin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Icodec Insulin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Icodec Insulin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Icodec Insulin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Icodec Insulin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Icodec Insulin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Icodec Insulin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Icodec Insulin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Icodec Insulin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Icodec Insulin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Icodec Insulin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Icodec Insulin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Icodec Insulin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Icodec Insulin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Icodec Insulin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Icodec Insulin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Icodec Insulin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Icodec Insulin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Icodec Insulin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Icodec Insulin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Icodec Insulin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Icodec Insulin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Icodec Insulin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Icodec Insulin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Icodec Insulin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Icodec Insulin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Icodec Insulin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Icodec Insulin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Icodec Insulin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Icodec Insulin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Icodec Insulin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Icodec Insulin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Icodec Insulin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Icodec Insulin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Icodec Insulin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Icodec Insulin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Icodec Insulin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Icodec Insulin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Icodec Insulin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Icodec Insulin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Icodec Insulin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Icodec Insulin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Icodec Insulin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Icodec Insulin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Icodec Insulin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Paijin Biotechnology
  2. 8.1.1 Paijin Biotechnology Company Information
  3. 8.1.2 Paijin Biotechnology Business Overview
  4. 8.1.3 Paijin Biotechnology Icodec Insulin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Paijin Biotechnology Icodec Insulin Product Portfolio
  6. 8.1.5 Paijin Biotechnology Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Icodec Insulin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Icodec Insulin Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Lilly
  14. 8.3.1 Lilly Company Information
  15. 8.3.2 Lilly Business Overview
  16. 8.3.3 Lilly Icodec Insulin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Lilly Icodec Insulin Product Portfolio
  18. 8.3.5 Lilly Recent Developments
  19. 8.4 Gan&Lee Pharmaceuticals
  20. 8.4.1 Gan&Lee Pharmaceuticals Company Information
  21. 8.4.2 Gan&Lee Pharmaceuticals Business Overview
  22. 8.4.3 Gan&Lee Pharmaceuticals Icodec Insulin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Gan&Lee Pharmaceuticals Icodec Insulin Product Portfolio
  24. 8.4.5 Gan&Lee Pharmaceuticals Recent Developments
  25. 8.5 Novo Nordisk
  26. 8.5.1 Novo Nordisk Company Information
  27. 8.5.2 Novo Nordisk Business Overview
  28. 8.5.3 Novo Nordisk Icodec Insulin Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Novo Nordisk Icodec Insulin Product Portfolio
  30. 8.5.5 Novo Nordisk Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Icodec Insulin Value Chain Analysis
  2. 9.1.1 Icodec Insulin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Icodec Insulin Sales Mode & Process
  6. 9.2 Icodec Insulin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Icodec Insulin Distributors
  9. 9.2.3 Icodec Insulin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst